Fred Mermelstein Overview

  • Investor Type
  • Angel

  • Investments
  • 1

  • Exits
  • 1


Fred Mermelstein General Information


Mr. Fred Mermelstein serves as President at Javelin Pharmaceuticals. He is an Angel Investor. He completed his post-doctoral training supported by two grant awards; a National Institutes of Health fellowship and a Howard Hughes Medical Institute fellowship in the Department of Biochemistry at UMDNJ Robert Wood Johnson Medical School.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • 125 CambridgePark Drive
  • Cambridge, MA 02140
  • United States

Fred Mermelstein Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
00 00000000000 27-May-2016 00000 00000 00000 Drug Discovery Generating Revenue
To view Fred Mermelstein’s complete investments history, request access »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fred Mermelstein Exits (1)

Company Name Exit Date Exit Type Exit Size
00 00000000000 30-Apr-2018 0000000000
To view Fred Mermelstein’s complete exits history, request access »

Fred Mermelstein Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Fred Mermelstein Team (1)

Name Title Deals Funds Boards Office
Fred Mermelstein Ph.D Angel Investor Cambridge, MA
To view Fred Mermelstein’s complete team members history, request access »